Clinical trial Recruiting at 1 site Observational Ages 18 to 55

Visual Analog Scale–Guided Multimodal Pain Plan After Posterior Rib Remodeling

Official title: Prospective Feasibility, Analgesic Effectiveness, and Safety Study of a Visual Analog Scale-Guided Multimodal Pain Algorithm After Posterior Rib Remodeling With Osteosynthesis

Run by Research Inc · NCT07805928 · Data updated 2026-11-12

This study tests a pain management plan guided by a 0–10 pain score to see if it keeps postoperative pain low after posterior rib remodeling with osteosynthesis.

Quick facts

Study typeObservational
Ages18 Years to 55 Years
SexAll
Enrollment160 (estimated)
SponsorResearch Inc
Industry-sponsored
Locations1 site (Bogotá)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 12, 2025
Study endsDecember 1, 2026
Registry record updatedSeptember 8, 2026
Trial IDNCT07805928 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–55 undergoing posterior aesthetic rib remodeling with osteosynthesis using the RIBOSS technique, who can reliably report pain scores and complete 5 days of monitoring.

Probably not a fit

Patients who do not experience adequate pain control with the predefined algorithm or who have contraindications to the planned analgesic components may see limited benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-group study evaluating a pain algorithm guided by a visual analog scale in the first five postoperative days after posterior rib remodeling with osteosynthesis. Pain is measured at multiple time points and treatment is adjusted based on predefined pain tiers and safety rules. The primary outcome is the proportion of pain assessments with scores of 3 or lower, with additional data on protocol adherence, rescue therapy, medication exposure, and adverse events. The approach includes a base nonopioid regimen for mild pain, augmented multimodal strategies for moderate pain, and full multimodal infusion with regional blocks for severe pain. The study also uses an ultrasound-guided regional block as part of the analgesia pathway and collects detailed safety and tolerability information.

Why it matters

Potential benefit: If successful, the algorithm could improve pain control and reduce unnecessary opioid use after chest wall surgery.

How similar studies have gone: Prior studies in multimodal analgesia and pain-guided pathways suggest potential benefits, but this specific VAS-guided protocol after RIBOSS is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 55 years.
* Scheduled for posterior aesthetic rib remodeling with osteosynthesis using the standardized RIBOSS technique.
* Ability to understand and use a 0-to-10 visual analog or numeric pain scale.
* Availability for scheduled pain assessments through postoperative hour 120.
* Written informed consent.

Exclusion Criteria:

* Chronic opioid use or opioid use disorder requiring an individualized perioperative plan.
* Contraindication to the base nonsteroidal anti-inflammatory drug or acetaminophen regimen and inability to use the predefined alternative pathway.
* Contraindication to ketamine, lidocaine, dexmedetomidine, or the planned regional block when those components may be required.
* Severe hepatic, renal, cardiac, neurologic, or psychiatric condition judged to make the algorithm unsafe.
* Pregnancy or breastfeeding.
* Inability to provide reliable pain scores or complete five-day monitoring.

Where it's running

  • Clinica INO
    Bogotá, Colombia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • CYT-1010 in healthy volunteers and after third molar extraction

    This trial tests CYT-1010, at single rising doses, for safety and tolerability in healthy adults and in people experiencing pain after removing wisdom teeth.

    Recruiting Phase 1/2 Cytogel Pharma, LLC · Salt Lake City, Utah · NCT07905105

  • Pharmacogenetics of Tramadol Pain Control in Postoperative Care

    This study tests whether CYP2D6 genetic differences affect how well tramadol works and its side effects in people recovering from surgery who all receive the same tramadol pump.

    Recruiting Research Inc · Medellín, Antioquia · NCT07810816

  • TENS for acute pain after VATS surgery

    A randomized, sham-controlled test will see if Transcutaneous Electrical Nerve Stimulation helps with acute pain after VATS surgery in adults and older teens.

    Recruiting Fooyin University · Kaohsiung City, Kaohsiung City · NCT07732764

  • DIPB vs SIFIB for pain control after total hip replacement

    This will test whether the Deep Iliacus Plane Block (DIPB) or the Suprainguinal Fascia Iliaca Block (SIFIB) gives better pain relief and less leg weakness for adults having elective total hip replacement.

    Recruiting Sivas Numune Hospital · Sivas, Sivas and 1 other locations · NCT07452120

  • Buprenorphine via PCA vs oxycodone for pain after VATS

    This trial tests whether intravenous buprenorphine given through a patient-controlled pump provides better and safer pain relief than intravenous oxycodone after video-assisted thoracic surgery in adults.

    Recruiting Phase 4 Medical University of Silesia · Zabrze, Silesian Voivodeship · NCT07434427

  • Continuous versus single adductor canal nerve block for outpatient total knee replacement

    This test checks whether adding a 5-day continuous adductor canal nerve block to the usual single injection lowers pain and opioid use after outpatient total knee replacement.

    Recruiting Phase 4 University of California, San Diego · La Jolla, California · NCT06784882

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.